Week in Review
Ariad Pharmaceuticals Inc. raised $224 million in a public stock offering.
Cell Therapeutics Inc. is raising $20 million in a registered direct offering of stock and warrants.
Cerulean Pharma Inc. closed a $15 million Series D financing.
Ember Therapeutics raised $34 million in Series A financing for obesity and diabetes drugs.
ImmusanT Inc. raised $20 million in a Series A round for celiac disease vaccine Nexvax2.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST